Company Filing History:
Years Active: 2025
Title: Patricia Andres: Innovator in Pharmaceutical Chemistry
Introduction
Patricia Andres is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of KRas G12C inhibitors. With a total of 2 patents, her work is paving the way for advancements in cancer treatment.
Latest Patents
Patricia's latest patents focus on crystalline forms of a KRas G12C inhibitor. The present invention relates to crystalline forms of the KRas G12C inhibitor 2-[(2S)-4-[7-(8-chloro-1-naphthyl)-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-1-(2-fluoroprop-2-enoyl)piperazin-2-yl]acetonitrile. This invention includes pharmaceutical compositions comprising the crystalline forms, processes for preparing the crystalline forms, and methods of use thereof.
Career Highlights
Patricia Andres is currently associated with Mirati Therapeutics, Inc., where she continues to innovate in the pharmaceutical sector. Her expertise in developing targeted therapies has positioned her as a key player in the industry.
Collaborations
Some of her notable coworkers include Samuel Andrew and Cheng Yi Chen. Their collaborative efforts contribute to the advancement of research and development in their field.
Conclusion
Patricia Andres is a trailblazer in pharmaceutical innovation, with her work on KRas G12C inhibitors showcasing her commitment to improving cancer therapies. Her contributions are vital to the ongoing advancements in medical science.